Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-336661
Filing Date
2018-11-28
Accepted
2018-11-28 16:54:32
Documents
53
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 6-K d629644d6k.htm 6-K 12529
2 EX-99.1 d629644dex991.htm EX-99.1 217231
3 EX-99.2 d629644dex992.htm EX-99.2 93536
4 EX-99.3 d629644dex993.htm EX-99.3 96888
  Complete submission text file 0001193125-18-336661.txt   2023415

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ncna-20180930.xml EX-101.INS 314309
6 XBRL TAXONOMY EXTENSION SCHEMA ncna-20180930.xsd EX-101.SCH 32958
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ncna-20180930_cal.xml EX-101.CAL 44785
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ncna-20180930_def.xml EX-101.DEF 63569
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ncna-20180930_lab.xml EX-101.LAB 200470
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ncna-20180930_pre.xml EX-101.PRE 144274
Mailing Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT
Business Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT 44-0-131-357-1111
NuCana plc (Filer) CIK: 0001709626 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38215 | Film No.: 181206178
SIC: 2834 Pharmaceutical Preparations